Califf Lowering FDA Drawbridge To Work With External Expertise
Executive Summary
In Pink Sheet's exclusive interview, new commissioner says FDA will tap knowledge beyond its walls, without compromising agency independence.
You may also be interested in...
Califf Likely To Find Many Familiar Problems Upon Return To US FDA Helm
President Biden’s pick for FDA commissioner should remember many of the hot-button issues that he would face upon confirmation, such as drug pricing and approval standards.
Robert Califf Likely To Find Many Familiar Problems Upon His Return To US FDA
President Biden’s pick for FDA commissioner should remember many of the hot-button issues that he would face upon confirmation, such as drug pricing and approval standards.
US FDA Still Waiting For Cures Money, Woodcock Says
When asked about Cures-related hiring, CDER Director says to her knowledge, no funding has been received yet.